SCICLONE PHARMACEUTICALS INC 4
4 · SCICLONE PHARMACEUTICALS INC · Filed Jun 14, 2017
Insider Transaction Report
Form 4
Low Raymond Anthony
VP, Finance & Controller
Transactions
- Exercise/Conversion
Restricted Stock Unit
2017-06-12−1,250→ 21,250 total→ Common Stock (1,250 underlying) - Exercise/Conversion
Common Stock
2017-06-12+1,250→ 15,536 total
Footnotes (4)
- [F1]Includes 773 shares purchased under the Issuer's Employee Purchase Plan on May 31, 2017.
- [F2]Granted under the Issuer's 2005 Equity Incentive Plan.
- [F3]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- [F4]Vesting for such RSUs will occur 25% on March 16, 2016, 25% on March 16, 2017, 25% on March 16, 2018, and 25% on March 16, 2019, or on such later date thereafter as the Company's trading window opens, if it is not open on any of such dates, contingent upon the executive's continued employment.